Several new variants of SARS-CoV-2 have emerged globally raising concern about prevention and treatment of COVID-19. SARS-CoV-2 is the highly transmissible etiologic agent of coronavirus disease 2019 (COVID-19) and has become a global scientific and public health challenge since December 2019. Genomic surveillance of SARS-CoV-2 in the state of Delaware reveals tremendous genomic diversity Genomic surveillance of SARS-CoV-2 in the state of Delaware reveals. Emergence of novel combinations of SARS-CoV-2 spike receptor binding domain variants in Senegal The emergence, genomic diversity and global spread of SARS-CoV-2 The emergence, genomic diversity and global spread of SARS-CoV-2Įmergence of novel combinations of SARS-CoV-2 spike receptor binding domain. A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Québec, Canada Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia GiuliaĪ small number of early introductions seeded widespread transmission of SARS. Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli. Occurrence of a substitution or deletion of SARS-CoV-2 spike amino acid 677 in various lineages in Marseille, France
Occurrence of a substitution or deletion of SARS-CoV-2 spike amino acid 677. Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York